UK doctors review Real-World results for bleeding disorder treatment
NCT ID NCT06433778
Summary
This study looked back at medical records to see how well a treatment called vonicog alfa worked for adults in the UK with von Willebrand disease (VWD), a common inherited bleeding disorder. Researchers reviewed data from 34 adults to understand how the treatment controlled bleeding episodes and helped prevent bleeding during surgeries. The goal was to gather real-world information on treatment effectiveness and healthcare use, not to test a new therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASE (VWD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Imperial College Healthcare
London, W2 1NY, United Kingdom
-
Leeds Teaching Hospital
Leeds, LS9 7TF, United Kingdom
-
Liverpool University Hospital
Liverpool, L7 8XP, United Kingdom
-
Manchester University
Manchester, M13 9WL, United Kingdom
-
Oxford University Hospital
Oxford, OX3 9DU, United Kingdom
-
Royal Free London
London, NW3 2QG, United Kingdom
-
University Hospitals Birmingham
Birmingham, B15 2GW, United Kingdom
Conditions
Explore the condition pages connected to this study.